Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Aprea Therapeutics, Inc. | Director | Common Stock | 34.7K | $253K | $7.29 | Jun 20, 2024 | Direct |
Aptose Biosciences Inc. | Director | Common Shares | 17K | $53.4K | $3.14 | Sep 22, 2023 | Direct |
Aprea Therapeutics, Inc. | Director | Stock Options (Right to Buy) | 4.19K | Jun 20, 2024 | Direct | ||
Aprea Therapeutics, Inc. | Director | Tranche A Warrant | 3.43K | Mar 13, 2024 | Direct | ||
Aprea Therapeutics, Inc. | Director | Tranche B Warrant | 3.43K | Mar 13, 2024 | Direct | ||
Aptose Biosciences Inc. | Director | Director Stock Option (Right to Buy) | 3.33K | Feb 5, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
APRE | Aprea Therapeutics, Inc. | Jun 20, 2024 | 2 | $0 | 4 | Jun 21, 2024 | Director |
APRE | Aprea Therapeutics, Inc. | Mar 13, 2024 | 3 | $50K | 4 | Mar 14, 2024 | Director |
APTO | Aptose Biosciences Inc. | Feb 5, 2024 | 1 | $0 | 4 | Feb 7, 2024 | Director |
APTO | Aptose Biosciences Inc. | Sep 22, 2023 | 1 | $53.4K | 4 | Sep 25, 2023 | Director |
APRE | Aprea Therapeutics, Inc. | Aug 23, 2023 | 2 | $0 | 4 | Aug 24, 2023 | Director |
APRE | Aprea Therapeutics, Inc. | Jun 6, 2023 | 2 | $37K | 4 | Jun 8, 2023 | Director |
APTO | Aptose Biosciences Inc. | Jan 19, 2023 | 1 | $0 | 4 | Jan 23, 2023 | Director |
APTO | Aptose Biosciences Inc. | Sep 14, 2022 | 1 | $0 | 4 | Sep 16, 2022 | Director |
APTO | Aptose Biosciences Inc. | Sep 13, 2022 | 0 | $0 | 3 | Sep 16, 2022 | Director |
APRE | Aprea Therapeutics, Inc. | Jul 28, 2022 | 2 | $0 | 4 | Aug 1, 2022 | Director |
APRE | Aprea Therapeutics, Inc. | May 18, 2022 | 1 | $35.5K | 4 | May 19, 2022 | Director |
APRE | Aprea Therapeutics, Inc. | Jun 30, 2021 | 2 | $0 | 4 | Jul 1, 2021 | Director |